ACHIKO AG/ CH0522213468 /
10/10/2023 3:49:31 PM | Chg. 0.000 | Volume | Bid- | Ask- | High | Low |
---|---|---|---|---|---|---|
0.001CHF | 0.00% | 10 Turnover: .014 |
-Bid Size: - | -Ask Size: - | 0.001 | 0.001 |
GlobeNewswire
1/27/2022
Achiko AG Strengthens Senior Team with Appointment of Head of Corporate Development
GlobeNewswire
1/18/2022
Achiko AG Announces Feature Article on “How We Get Back to Normal” with its AptameX™ Covid-19 Rapid ...
GlobeNewswire
1/14/2022
Achiko AG Reports Breakthrough Calibration Results for its AptameX™ Covid-19 Rapid Test Technology
GlobeNewswire
12/23/2021
Achiko AG Looks Back at Pivotal Year and Reaffirms Commitment to Provide Affordable and Accurate COV...
GlobeNewswire
12/8/2021
Achiko’s Commercialization Update: Optimized Second-Generation Covid-19 Diagnostic Test Receives Ful...
GlobeNewswire
8/25/2021
Achiko’s Rapid Covid-19 Diagnostic Test AptameX™ Receives Product and Registration Approval from Ind...
GlobeNewswire
7/15/2021
Achiko Engages EpiMetrics to Expand Covid-19 Testing Operations with Udayana University in Bali, Ind...
GlobeNewswire
6/18/2021
Achiko Announces an Extension of its Convertible Loan Transaction with Negma Group
GlobeNewswire
6/3/2021
Achiko Announces the Successful Integration of its Teman Sehat Digital Ecosystem and AptameX Covid-1...
GlobeNewswire
6/3/2021
Achiko AG Announces Successful Integration of its Teman Sehat Digital Ecosystem and AptameX Covid-19...
GlobeNewswire
5/20/2021
Achiko Completes Initial Shipment of AptameX, its Progressive Covid-19 Diagnostic Test to Indonesia,...
GlobeNewswire
5/4/2021
Achiko Appoints New Chief Financial Officer and Announces Changes to Senior Team